The National Centre for Asbestos Related Diseases (NCARD) is proud to release its 2024 Annual Report. This year’s report highlights our research achievements, including: Discovery of blood biomarkers that can…
More than 3,000 donors and their families have helped shape new tests, treatments and hope for the future. For over 30 years, the NCARD Biobank has quietly underpinned some of…
An expert in mesothelioma from The University of Western Australia has been honoured with a prestigious award in recognition of his contribution to patient care, innovation in treatment and development…
A breakthrough clinical trial has found that combining a new drug with chemotherapy treatment improved survival rates of malignant mesothelioma patients. The study, published in JAMA Oncology, was led by…
We are thrilled to announce recent grant success for the National Centre for Asbestos Related Diseases (NCARD) and our very own A/Prof Alec Redwood. Alec, a recognized expert in the…
The National Centre for Asbestos Related Diseases (NCARD) recently hosted its annual Scientific Symposium, a hallmark event that united top experts in mesothelioma research. The day was filled with discussions…
Welcome to the release of our latest annual report, where we present a comprehensive overview of the impactful work undertaken by the National Centre for Asbestos Related Diseases (NCARD) over…
A molecular immunologist from The University of Western Australia with a distinguished track record in researching asbestos related cancer has been presented with a prestigious award by the Asbestos Diseases…
Congratulations to all of the NCARD PhD students for fantastic 3 Minute Thesis (3MT) presentations at the 2021 Annual Scientific Meeting. As anyone who has considered the 3MT, a competition…
The 14th NCARD Annual Scientific Meeting was held on 16 & 17 September 2021 in the McCusker Auditorium of the Perkins Institute of Medical Research, and included a Public Lecture…